ClinicalTrials.Veeva

Menu

Transgender Observational Performance (TOP)

I

Instituto Brasileiro de Controle do Cancer

Status

Unknown

Conditions

Transgender Persons

Treatments

Other: Aerobic exercise test.

Study type

Observational

Funder types

Other

Identifiers

NCT05337865
52428321.2.0000.0062

Details and patient eligibility

About

The study will evaluate the sports capabilities of transgender women mainly in terms of muscular strength and aerobic capacity (VO2max). The control group will be composed of cisgender women and cisgender men with the same levels of physical activity.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Diagnosis of a transgender woman by the DSM-V or ICD10.
  • Gonadectomized and non-gonadectomized
  • Initiation of androgen blockade and/or estrogen use after 12 years of age.
  • Age range 18 to 50 years old.
  • BMI: 18.0 to 34.9 kg/m2.
  • Well-trained individuals (IPAQ very active)

Exclusion criteria

  • Current or previous morbidities that could interfere with strength or aerobic tests.
  • Chronic illnesses and/or chronic medication use.
  • Musculoskeletal limitations.

Trial design

60 participants in 3 patient groups

Transgender women
Description:
Well-trained transgender women.
Treatment:
Other: Aerobic exercise test.
Cisgender Women
Description:
Well-trained cisgender women.
Treatment:
Other: Aerobic exercise test.
Cisgender Men
Description:
Well-trained cisgender men.
Treatment:
Other: Aerobic exercise test.

Trial contacts and locations

0

Loading...

Central trial contact

Raphael Einsfeld, Phd; Leonardo Alvares, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems